Announcements

Remarks by Dr. Jerome Kim, Director General of IVI, during the 2021 IVI State Forum

IVI’s Statement for the Global COVID-19 Summit: Ending the Pandemic and Building Back Better

Opening remarks by Dr. Jerome Kim, Director General of IVI, during President Iván Duque of the Republic of Colombia’s Official Visit to IVI and the Republic of Korea

Leading experts suggest comprehensive post-efficacy strategy required after demonstrated efficacy of COVID-19 vaccines in Nature Medicine commentary

Gender Equality at IVI

Statement of Clarification

Announcing the winners of the IVI Slogan Competition 2020

The Embassy of China in Seoul donates 20,000 USD to IVI to support vaccine R&D

The Strep A Vaccine Global Consortium (SAVAC) launches new microsite

Honoring a life-long advocate for vaccine science and equity

LG Chairman Koo Kwang-Mo personally donates 1 billion KRW to IVI to support COVID-19 vaccine development

IVI Slogan Competition 2020

IVI’s statement on environmental sustainability

USask VIDO-InterVac and International Vaccine Institute collaborate on COVID-19 work

IVI at work on COVID-19

IVI thanks four exemplary leaders for their service on the IVI Board of Trustees

IVI and the World Society for Virology exchange MOU to strengthen virology research and network

IVI and the USask’s VIDO-InterVac Exchange MOU to Advance Vaccine Research

The CNBG and IVI exchange MOU to provide high-quality vaccines to developing countries

IVI co-organizes the 2019 International Vaccine Industry Forum with GIB

IVI teams up with 4 Korean partners to nurture vaccine industry professionals

IVI´s Board of Trustees welcomes new members at annual meeting

IVI presents growing impact on global health with 2018 Annual Report

Former KSC Vice President Ms. Joanne Lee donates 50 million KRW to IVI

IVI scientists’ paper recommended by Faculty of 1000 Biology, and Korea’s bioscience portal

IVI Forum for Enhancement of Cooperation

Typhoid conjugate vaccine from Indonesia found to be safe, immunogenic in phase 1 clinical trial

Announcements

Announcements

Remarks by Dr. Jerome Kim, Director General of IVI, during the 2021 IVI State Forum

IVI’s Statement for the Global COVID-19 Summit: Ending the Pandemic and Building Back Better

Opening remarks by Dr. Jerome Kim, Director General of IVI, during President Iván Duque of the Republic of Colombia’s Official Visit to IVI and the Republic of Korea

INVITATION FOR BID_Purchase of Lyophilizer at IVI

IVI forms an ESG Committee

IVI remembers Bagrey Ngwira

Leading experts suggest comprehensive post-efficacy strategy required after demonstrated efficacy of COVID-19 vaccines in Nature Medicine commentary

Gender Equality at IVI

Statement of Clarification

Announcing the winners of the IVI Slogan Competition 2020

The Embassy of China in Seoul donates 20,000 USD to IVI to support vaccine R&D

The Strep A Vaccine Global Consortium (SAVAC) launches new microsite

Honoring a life-long advocate for vaccine science and equity

LG Chairman Koo Kwang-Mo personally donates 1 billion KRW to IVI to support COVID-19 vaccine development

IVI Slogan Competition 2020

IVI’s statement on environmental sustainability

USask VIDO-InterVac and International Vaccine Institute collaborate on COVID-19 work

IVI at work on COVID-19

IVI thanks four exemplary leaders for their service on the IVI Board of Trustees

IVI and the World Society for Virology exchange MOU to strengthen virology research and network

IVI and the USask’s VIDO-InterVac Exchange MOU to Advance Vaccine Research

The CNBG and IVI exchange MOU to provide high-quality vaccines to developing countries

IVI co-organizes the 2019 International Vaccine Industry Forum with GIB

IVI teams up with 4 Korean partners to nurture vaccine industry professionals

IVI´s Board of Trustees welcomes new members at annual meeting

IVI presents growing impact on global health with 2018 Annual Report

Former KSC Vice President Ms. Joanne Lee donates 50 million KRW to IVI

IVI scientists’ paper recommended by Faculty of 1000 Biology, and Korea’s bioscience portal

IVI Forum for Enhancement of Cooperation

Typhoid conjugate vaccine from Indonesia found to be safe, immunogenic in phase 1 clinical trial

Prof. John D. Clemens, former Director General of IVI, honored with The Prince Mahidol Award in public health

BOT meets face-to-face and visits KCDC & LG Chem’s vaccine plant

Scientific Advisory Group (SAG) gathers for 17th meeting

Welcome to our new website!

Social Media